ZA201001912B - Identification and isolation of fetal cells and nucleic acid - Google Patents
Identification and isolation of fetal cells and nucleic acidInfo
- Publication number
- ZA201001912B ZA201001912B ZA2010/01912A ZA201001912A ZA201001912B ZA 201001912 B ZA201001912 B ZA 201001912B ZA 2010/01912 A ZA2010/01912 A ZA 2010/01912A ZA 201001912 A ZA201001912 A ZA 201001912A ZA 201001912 B ZA201001912 B ZA 201001912B
- Authority
- ZA
- South Africa
- Prior art keywords
- isolation
- identification
- nucleic acid
- fetal cells
- fetal
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97439207P | 2007-09-21 | 2007-09-21 | |
PCT/US2008/077251 WO2009039507A2 (en) | 2007-09-21 | 2008-09-22 | Identification and isolation of fetal cells and nucleic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201001912B true ZA201001912B (en) | 2011-05-25 |
Family
ID=40468814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2010/01912A ZA201001912B (en) | 2007-09-21 | 2010-03-17 | Identification and isolation of fetal cells and nucleic acid |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP2207879A4 (en) |
JP (1) | JP2010539906A (en) |
KR (1) | KR20100061539A (en) |
CN (1) | CN101883851A (en) |
AU (1) | AU2008302040A1 (en) |
BR (1) | BRPI0817199A2 (en) |
CA (1) | CA2699958A1 (en) |
IL (1) | IL204585A0 (en) |
MX (1) | MX2010003116A (en) |
NZ (1) | NZ584165A (en) |
WO (1) | WO2009039507A2 (en) |
ZA (1) | ZA201001912B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8476013B2 (en) * | 2008-09-16 | 2013-07-02 | Sequenom, Inc. | Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
US8962247B2 (en) | 2008-09-16 | 2015-02-24 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses |
US20120100538A1 (en) | 2009-03-24 | 2012-04-26 | Biocept, Inc. | Devices and methods of cell capture and analysis |
US9128082B2 (en) | 2009-03-24 | 2015-09-08 | Biocept, Inc. | Devices and methods of cell capture and analysis |
EP3660165B1 (en) | 2009-12-22 | 2023-01-04 | Sequenom, Inc. | Processes and kits for identifying aneuploidy |
US9605313B2 (en) | 2012-03-02 | 2017-03-28 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
US9920361B2 (en) | 2012-05-21 | 2018-03-20 | Sequenom, Inc. | Methods and compositions for analyzing nucleic acid |
WO2013192620A1 (en) | 2012-06-22 | 2013-12-27 | Quantrx Biomedical Corporation | Method for obtaining fetal cells and fetal cellular components |
US20140093873A1 (en) | 2012-07-13 | 2014-04-03 | Sequenom, Inc. | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses |
EP3597774A1 (en) | 2013-03-13 | 2020-01-22 | Sequenom, Inc. | Primers for dna methylation analysis |
EP3117011B1 (en) | 2014-03-13 | 2020-05-06 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
CN110352243B (en) * | 2017-03-27 | 2024-05-28 | 积水医疗株式会社 | Method for concentrating and recovering target nucleic acid using antibody |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09510875A (en) * | 1994-03-29 | 1997-11-04 | ジェンザイム・コーポレイション | Culture and isolation of fetal cells from maternal peripheral blood |
CA2476835A1 (en) * | 2002-02-20 | 2003-08-28 | University Of Virginia Patent Foundation | A non-invasive diagnostic test utilizing histone modification markers |
GB0211904D0 (en) * | 2002-05-23 | 2002-07-03 | Medical Res Council | Nuclear transfer |
US20050181429A1 (en) * | 2003-04-03 | 2005-08-18 | Monaliza Medical Ltd. | Non-invasive prenatal genetic diagnosis using transcervical cells |
US20040197832A1 (en) * | 2003-04-03 | 2004-10-07 | Mor Research Applications Ltd. | Non-invasive prenatal genetic diagnosis using transcervical cells |
US20070243549A1 (en) * | 2006-04-12 | 2007-10-18 | Biocept, Inc. | Enrichment of circulating fetal dna |
-
2008
- 2008-09-22 AU AU2008302040A patent/AU2008302040A1/en not_active Abandoned
- 2008-09-22 MX MX2010003116A patent/MX2010003116A/en unknown
- 2008-09-22 CA CA2699958A patent/CA2699958A1/en not_active Abandoned
- 2008-09-22 BR BRPI0817199-8A2A patent/BRPI0817199A2/en not_active IP Right Cessation
- 2008-09-22 JP JP2010526048A patent/JP2010539906A/en active Pending
- 2008-09-22 NZ NZ584165A patent/NZ584165A/en not_active IP Right Cessation
- 2008-09-22 KR KR1020107008140A patent/KR20100061539A/en not_active Application Discontinuation
- 2008-09-22 CN CN2008801087518A patent/CN101883851A/en active Pending
- 2008-09-22 WO PCT/US2008/077251 patent/WO2009039507A2/en active Application Filing
- 2008-09-22 EP EP08831741A patent/EP2207879A4/en not_active Withdrawn
-
2010
- 2010-03-17 ZA ZA2010/01912A patent/ZA201001912B/en unknown
- 2010-03-18 IL IL204585A patent/IL204585A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2008302040A1 (en) | 2009-03-26 |
KR20100061539A (en) | 2010-06-07 |
BRPI0817199A2 (en) | 2014-10-14 |
CA2699958A1 (en) | 2009-03-26 |
EP2207879A4 (en) | 2011-01-26 |
JP2010539906A (en) | 2010-12-24 |
MX2010003116A (en) | 2010-08-03 |
NZ584165A (en) | 2012-09-28 |
EP2207879A2 (en) | 2010-07-21 |
CN101883851A (en) | 2010-11-10 |
WO2009039507A3 (en) | 2009-06-18 |
IL204585A0 (en) | 2010-11-30 |
WO2009039507A2 (en) | 2009-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL204585A0 (en) | Identification and isolation of fetal cells and nucleic acid | |
GB0701253D0 (en) | Nucleic acid amplification and testing | |
GB0814570D0 (en) | Isolation of nucleic acid | |
IL214034A0 (en) | Single -cell nucleic acid analysis | |
PL2334786T3 (en) | Isolation and identification of glycosaminoglycans | |
EP2356259A4 (en) | Products and processes for multiplex nucleic acid identification | |
HK1171083A1 (en) | Nucleic acid analysis | |
EP2229457A4 (en) | Gender-specific separation of sperm cells and embryos | |
EP2242857A4 (en) | Method for isolating cell free apoptotic or fetal nucleic acids | |
EP2414545A4 (en) | Nucleic acid preparation compositions and methods | |
EP2207896A4 (en) | Nucleic acid amplification | |
EP2310524A4 (en) | Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids | |
GB0910302D0 (en) | Nucleic acid amplification | |
IL217370A (en) | Nucleic acid prodrugs and methods of use thereof | |
PT3375891T (en) | Methods and devices for compensation of spectral crosstalk in multiplex nucleic acid amplification | |
EP2115123A4 (en) | Selective lysis of sperm cells | |
EP2481800A4 (en) | Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof | |
ZA201102195B (en) | Methods and compositions for isolating nucleic acid | |
HK1118859A1 (en) | Nucleic acid isolation using polidocanol and derivatives | |
HK1142928A1 (en) | Nucleic acid amplification in the presence of modified randomers | |
GB0812862D0 (en) | Nucleic acid amplification | |
PL2248913T3 (en) | GNLY as epigenetic marker for the identification of CD56-expressing natural killer cells | |
EP2300488A4 (en) | Cell lysis reagent for isolation of rna | |
EP2333059A4 (en) | Universal nucleic acid probe set and method for utilization thereof | |
EP2195453A4 (en) | Method of amplifying nucleic acid |